Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention
Paul Guedeney(Université Paris Cité), Roxana Mehran(Mount Sinai Hospital), Annapoorna Kini(Mount Sinai Medical Center), Michela Faggioni(Cardiovascular Institute of the South), Sabato Sorrentino(Magna Graecia University), Birgit Vogel(Cardiovascular Institute of the South), Deborah N. Kalkman(Cardiovascular Institute of the South), Pedro Moreno(Mount Sinai Hospital), Pooja Vijay(Mount Sinai Medical Center), Serdar Farhan(Mount Sinai Hospital), Srushthi Shah(Mount Sinai Medical Center), George Dangas(Mount Sinai Hospital), Nitin Barman(Icahn School of Medicine at Mount Sinai), Jaya Chandrasekhar(Icahn School of Medicine at Mount Sinai), Anton Camaj(Columbia University Irving Medical Center), Joseph Sweeny(Mount Sinai Hospital), Jason C. Kovacic(Victor Chang Cardiac Research Institute), Usman Baber(Cardiovascular Institute of the South), Melissa Aquino(Cardiovascular Institute of the South), Bimmer E. Claessen(Columbia University Irving Medical Center)
Cited by 8
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
|New England Journal of Medicine|2016|1.5k